These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2033 related items for PubMed ID: 19558249

  • 1. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
    MacLaren R, Bond CA.
    Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
    [Abstract] [Full Text] [Related]

  • 2. Clinical and economic outcomes of pharmacist-managed antiepileptic drug therapy.
    Bond CA, Raehl CL.
    Pharmacotherapy; 2006 Oct; 26(10):1369-78. PubMed ID: 16999646
    [Abstract] [Full Text] [Related]

  • 3. Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections.
    MacLaren R, Bond CA, Martin SJ, Fike D.
    Crit Care Med; 2008 Dec; 36(12):3184-9. PubMed ID: 18936700
    [Abstract] [Full Text] [Related]

  • 4. Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals.
    Bond CA, Raehl CL.
    Pharmacotherapy; 2006 Jun; 26(6):735-47. PubMed ID: 16716127
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the impact of a tele-ICU pharmacist on the management of sedation in critically ill mechanically ventilated patients.
    Forni A, Skehan N, Hartman CA, Yogaratnam D, Njoroge M, Schifferdecker C, Lilly CM.
    Ann Pharmacother; 2010 Mar; 44(3):432-8. PubMed ID: 20164471
    [Abstract] [Full Text] [Related]

  • 6. Clinical outcomes and resource utilization associated with laparoscopic and open colectomy using a large national database.
    Delaney CP, Chang E, Senagore AJ, Broder M.
    Ann Surg; 2008 May; 247(5):819-24. PubMed ID: 18438119
    [Abstract] [Full Text] [Related]

  • 7. Mortality and length-of-stay outcomes, 1993-2003, in the binational Australian and New Zealand intensive care adult patient database.
    Moran JL, Bristow P, Solomon PJ, George C, Hart GK, Australian and New Zealand Intensive Care Society Database Management Committee (ADMC).
    Crit Care Med; 2008 Jan; 36(1):46-61. PubMed ID: 18090383
    [Abstract] [Full Text] [Related]

  • 8. Pharmacist monitoring of QTc interval-prolonging medications in critically ill medical patients: a pilot study.
    Ng TM, Bell AM, Hong C, Hara JM, Touchette DR, Danskey KN, Lindsay TT, Puumala SE.
    Ann Pharmacother; 2008 Apr; 42(4):475-82. PubMed ID: 18319393
    [Abstract] [Full Text] [Related]

  • 9. Critical care pharmacy services in United States hospitals.
    Maclaren R, Devlin JW, Martin SJ, Dasta JF, Rudis MI, Bond CA.
    Ann Pharmacother; 2006 Apr; 40(4):612-8. PubMed ID: 16569803
    [Abstract] [Full Text] [Related]

  • 10. Clinical pharmacy services, pharmacy staffing, and hospital mortality rates.
    Bond CA, Raehl CL.
    Pharmacotherapy; 2007 Apr; 27(4):481-93. PubMed ID: 17381374
    [Abstract] [Full Text] [Related]

  • 11. A primer on critical care pharmacy services.
    Erstad BL.
    Ann Pharmacother; 2008 Dec; 42(12):1871-81. PubMed ID: 19017823
    [Abstract] [Full Text] [Related]

  • 12. Current management of anemia in critically ill patients: analysis of a database of 139 hospitals.
    Dasta J, Mody SH, McLaughlin T, Leblanc J, Shen Y, Genetti M, Raut MK, Piech CT.
    Am J Ther; 2008 Dec; 15(5):423-30. PubMed ID: 18806517
    [Abstract] [Full Text] [Related]

  • 13. Effect of a multiple-site intensive care unit telemedicine program on clinical and economic outcomes: an alternative paradigm for intensivist staffing.
    Breslow MJ, Rosenfeld BA, Doerfler M, Burke G, Yates G, Stone DJ, Tomaszewicz P, Hochman R, Plocher DW.
    Crit Care Med; 2004 Jan; 32(1):31-8. PubMed ID: 14707557
    [Abstract] [Full Text] [Related]

  • 14. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems.
    Westerlund T, Marklund B.
    J Clin Pharm Ther; 2009 Jun; 34(3):319-27. PubMed ID: 19646078
    [Abstract] [Full Text] [Related]

  • 15. Cost effectiveness of a clinical pharmacist on a neurosurgical team.
    Weant KA, Armitstead JA, Ladha AM, Sasaki-Adams D, Hadar EJ, Ewend MG.
    Neurosurgery; 2009 Nov; 65(5):946-50; discussion 950-1. PubMed ID: 19834408
    [Abstract] [Full Text] [Related]

  • 16. Clinical and financial impact of pharmacy services in the intensive care unit: pharmacist and prescriber perceptions.
    MacLaren R, Brett McQueen R, Campbell J.
    Pharmacotherapy; 2013 Apr; 33(4):401-10. PubMed ID: 23468188
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Epidemiology and impact of aspiration pneumonia in patients undergoing surgery in Maryland, 1999-2000.
    Kozlow JH, Berenholtz SM, Garrett E, Dorman T, Pronovost PJ.
    Crit Care Med; 2003 Jul; 31(7):1930-7. PubMed ID: 12847385
    [Abstract] [Full Text] [Related]

  • 19. Location of patients before transfer to a tertiary care intensive care unit: impact on outcome.
    Gerber DR, Schorr C, Ahmed I, Dellinger RP, Parrillo J.
    J Crit Care; 2009 Mar; 24(1):108-13. PubMed ID: 19272546
    [Abstract] [Full Text] [Related]

  • 20. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
    Poon IO, Lal L, Brown EN, Braun UK.
    J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 102.